MSB 3.21% $1.13 mesoblast limited

MSB 2023 - awaiting for Ryoncil approval, page-357

  1. 4,087 Posts.
    lightbulb Created with Sketch. 302
    It would seem they are confident and as they should be with ex FDA on their side now. They have stated that the file is in the hands of publishers so it been resubmitted.

    Case closed.

    First approval ahead
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.